Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care
SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ — Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity
Read More